Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Status: Enrolling
Updated:  8/17/2010
AHF Research Center
mi
from
Beverly Hills, CA
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Status: Enrolling
Updated: 8/17/2010
AHF Research Center
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Hepatocellular Research Registry
CellzDirect: Hepatocellular Research Registry
Status: Enrolling
Updated:  8/20/2010
Vanderbilt University
mi
from
Nashville, TN
Hepatocellular Research Registry
CellzDirect: Hepatocellular Research Registry
Status: Enrolling
Updated: 8/20/2010
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated:  8/20/2010
Specialty Hospital of Washington - Hadley
mi
from
Washington,
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
Specialty Hospital of Washington - Hadley
mi
from
Washington,
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated:  8/20/2010
Aiyan Diabetes Center
mi
from
Augusta, GA
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
Aiyan Diabetes Center
mi
from
Augusta, GA
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated:  8/20/2010
VA Southern Nevda
mi
from
Las Vegas, NV
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
VA Southern Nevda
mi
from
Las Vegas, NV
Click here to add this to my saved trials
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated:  8/20/2010
Providence Wound Institute
mi
from
El Paso, TX
The AutoloGel™ Post-Market Surveillance (TAPS) Program
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Status: Enrolling
Updated: 8/20/2010
Providence Wound Institute
mi
from
El Paso, TX
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #059
mi
from
Birmingham, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #059
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #042
mi
from
Huntsville, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #042
mi
from
Huntsville, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #033
mi
from
Montgomery, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #033
mi
from
Montgomery, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #067
mi
from
Scottsdale, AZ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #067
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #090
mi
from
Tucson, AZ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #090
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #068
mi
from
Jonesboro, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #068
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 10
mi
from
Little Rock, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 10
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #093
mi
from
Lowell, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #093
mi
from
Lowell, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site 062
mi
from
Fresno, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site 062
mi
from
Fresno, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #057
mi
from
Madera, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #057
mi
from
Madera, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #060
mi
from
Palm Springs, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #060
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #095
mi
from
Roseville, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #095
mi
from
Roseville, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #003
mi
from
San Carlos, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #003
mi
from
San Carlos, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #022
mi
from
San Diego, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #022
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #052
mi
from
Santa Monica, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #052
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #086
mi
from
West Covina, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #086
mi
from
West Covina, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 27
mi
from
Lafayette, CO
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 27
mi
from
Lafayette, CO
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #006
mi
from
Littleton, CO
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #006
mi
from
Littleton, CO
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational SIte #036
mi
from
Thornton, CO
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational SIte #036
mi
from
Thornton, CO
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #031
mi
from
Hamden, CT
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #031
mi
from
Hamden, CT
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #083
mi
from
Hartford, CT
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #083
mi
from
Hartford, CT
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #023
mi
from
Cape Coral, FL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #023
mi
from
Cape Coral, FL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #076
mi
from
Hollywood, FL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #076
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #007
mi
from
Jacksonville, FL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #007
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #008
mi
from
Miami, FL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #008
mi
from
Miami, FL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #027
mi
from
Sarasota, FL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #027
mi
from
Sarasota, FL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #066
mi
from
Winter Park, FL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #066
mi
from
Winter Park, FL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #005
mi
from
Atlanta, GA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #005
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #010
mi
from
Arlington Heights, IL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #010
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 53
mi
from
Chicago, IL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 53
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #089
mi
from
Peoria, IL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #089
mi
from
Peoria, IL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #059
mi
from
Anderson, IN
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #059
mi
from
Anderson, IN
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #015
mi
from
Davenport, IA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #015
mi
from
Davenport, IA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 20
mi
from
Topeka, KA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 20
mi
from
Topeka, KA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #039
mi
from
Baton Rouge, LA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #039
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #061
mi
from
Lafayette, LA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #061
mi
from
Lafayette, LA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site 092
mi
from
New Orleans, LA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site 092
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 4
mi
from
Shreveport, LA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 4
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 5
mi
from
Chevy Chase, MD
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 5
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #046
mi
from
Hagerstown, MD
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #046
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #035
mi
from
Laurel, MD
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #035
mi
from
Laurel, MD
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #025
mi
from
Lutherville, MD
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #025
mi
from
Lutherville, MD
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #037
mi
from
Boston, MA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #037
mi
from
Boston, MA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #018
mi
from
Braintree, MA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #018
mi
from
Braintree, MA
Click here to add this to my saved trials